Estudios originales
Published on 11 de noviembre de 2024 | http://doi.org/10.5867/medwave.2024.10.2939
Preventive behaviors for COVID-19 in Chile: Lessons from a population follow-up for 2021 and 2022
Back to article
Multiple linear regression model of the preventive practices scores, years 2021 to 2022, Chile.
City | Coquimbo - La Serena | Ref. | Ref. | ||||
Talca | 0.15 | 0.50 | -0.29 to 0.59 | -0.00 | 0.94 | -0.35 to 0.32 | |
Gender | Male | Ref | Ref | ||||
Female | 0.70 | 0.00 | 0.27 to 1.13 | 0.35 | 0.05 | -0.00 to 0.70 | |
Age | 7 to 19 | ref | Ref | ||||
20 to 29 | -0.59 | 0.20 | -1.49 to 0.31 | -0.25 | 0.51 | -0.99 to 0.49 | |
30 to 49 | 0.37 | 0.35 | -0.42 to 1.17 | 0.66 | 0.04 | 0.00 to 1.32 | |
50 to 59 | 0.02 | 0.96 | -0.89 to 0.85 | 0.45 | 0.23 | -0.29 to 1.18 | |
60 and above | 0.28 | 0.53 | -0.60 to 1.16 | 0.39 | 0.32 | -0.37to 1.15 | |
Body Mass Index (not included underweight) | Normal | Ref | Ref | ||||
Overweight/obesity | 0.52 | 0.03 | 0.06 to 0.98 | -0.08 | 0.68 | -0.46 to 0.30 | |
Comorbidity | No | Ref | |||||
Yes | 0.17 | 0.46 | -0.28 to 0.62 | 0.25 | 0.19 | -0.12 to 0.62 | |
In-person work | No | Ref. | Ref | ||||
Yes | -0.11 | 0.66 | -0.57 to 0.36 | -0.25 | 0.17 | -0.60 to 0.11 | |
Episodes of illness | No | ref. | Ref | ||||
Yes | -0.05 | 0.80 | -0.47 to 0.37 | -0.18 | 0.31 | -0.52 to 0.17 | |
Vaccine | No | Ref. | Ref. | ||||
Basal scheme (1 or 2 doses) | -0.57 | 0.40 | -1.90 to 0.77 | -0.91 | 0.34 | -2.79 to 0.97 | |
Basal scheme + 2 boosters | 0.12 | 0.87 | -1.27 to 1.51 | -0.92 | 0.31 | -2.68 to 0.85 | |
Basal scheme + 1 booster | -0.69 | 0.44 | -2.46 to 1.08 |
CI, confidence interval.
Source: Prepared by the authors based on the results of the study.